Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients
Gespeichert in:
| Veröffentlicht in: | Journal of the American Academy of Dermatology 2016-06, Vol.74 (6), p.1248-1251 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1251 |
|---|---|
| container_issue | 6 |
| container_start_page | 1248 |
| container_title | Journal of the American Academy of Dermatology |
| container_volume | 74 |
| creator | Fennira, Feriel, MD Chasset, François, MD Soubrier, Martin, MD, PhD Cordel, Nadège, MD Petit, Antoine, MD Francès, Camille, MD |
| description | |
| doi_str_mv | 10.1016/j.jaad.2016.01.054 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1789759181</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0190962216013323</els_id><sourcerecordid>1789759181</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-6b289d7f36e53d6f64be0fc89c4d62f33a5064d688a63f9319c0df2cea37623</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhS1E1Q6lf4AF8pJNgh-JHSOEVFW8pJFYlB0Ly2Nfqw5JPNhOpfn3OJrCggWb67s458rnOwi9oqSlhIq3Yzsa41pW95bQlvTdM7SjRMlGyEE-RztCFWmUYOwKvch5JISojstLdMUkHfqO9Tv0Yw-LmYKLc3CAfUw4gU_GlphO2D6kuASLzeJwXg_GrgVwHWaBuGY8rcc6IZ3KA8ymxLzmd5gKfDQlwFLyS3ThzZTh5um9RvefPn6_-9Lsv33-ene7b2zPaGnEgQ3KSc8F9NwJL7oDEG8HZTsnmOfc9ETUdRiM4F5xqixxnlkwXArGr9Gb89Vjir9WyEXPIVuYpvMvNZWDkr2iA61SdpbaFHOuQfUxhdmkk6ZEb0j1qDekekOqCdUVaTW9frq_HmZwfy1_GFbB-7MAasbHAElnW_NbcCGBLdrF8P_7H_6x2ylU6mb6CSfIY1xTbajm0Jlpou-3UrdOqSCUc8b5b7iGnWU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1789759181</pqid></control><display><type>article</type><title>Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Fennira, Feriel, MD ; Chasset, François, MD ; Soubrier, Martin, MD, PhD ; Cordel, Nadège, MD ; Petit, Antoine, MD ; Francès, Camille, MD</creator><creatorcontrib>Fennira, Feriel, MD ; Chasset, François, MD ; Soubrier, Martin, MD, PhD ; Cordel, Nadège, MD ; Petit, Antoine, MD ; Francès, Camille, MD</creatorcontrib><identifier>ISSN: 0190-9622</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2016.01.054</identifier><identifier>PMID: 27185425</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Chronic Disease ; Dermatology ; Female ; Humans ; Immunologic Factors - adverse effects ; Immunologic Factors - therapeutic use ; Lupus Erythematosus, Cutaneous - drug therapy ; Male ; Middle Aged ; Retreatment ; Thalidomide - adverse effects ; Thalidomide - analogs & derivatives ; Thalidomide - therapeutic use</subject><ispartof>Journal of the American Academy of Dermatology, 2016-06, Vol.74 (6), p.1248-1251</ispartof><rights>American Academy of Dermatology, Inc.</rights><rights>2016 American Academy of Dermatology, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-6b289d7f36e53d6f64be0fc89c4d62f33a5064d688a63f9319c0df2cea37623</citedby><cites>FETCH-LOGICAL-c521t-6b289d7f36e53d6f64be0fc89c4d62f33a5064d688a63f9319c0df2cea37623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0190962216013323$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27185425$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fennira, Feriel, MD</creatorcontrib><creatorcontrib>Chasset, François, MD</creatorcontrib><creatorcontrib>Soubrier, Martin, MD, PhD</creatorcontrib><creatorcontrib>Cordel, Nadège, MD</creatorcontrib><creatorcontrib>Petit, Antoine, MD</creatorcontrib><creatorcontrib>Francès, Camille, MD</creatorcontrib><title>Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><subject>Adult</subject><subject>Chronic Disease</subject><subject>Dermatology</subject><subject>Female</subject><subject>Humans</subject><subject>Immunologic Factors - adverse effects</subject><subject>Immunologic Factors - therapeutic use</subject><subject>Lupus Erythematosus, Cutaneous - drug therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Retreatment</subject><subject>Thalidomide - adverse effects</subject><subject>Thalidomide - analogs & derivatives</subject><subject>Thalidomide - therapeutic use</subject><issn>0190-9622</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUtv1DAUhS1E1Q6lf4AF8pJNgh-JHSOEVFW8pJFYlB0Ly2Nfqw5JPNhOpfn3OJrCggWb67s458rnOwi9oqSlhIq3Yzsa41pW95bQlvTdM7SjRMlGyEE-RztCFWmUYOwKvch5JISojstLdMUkHfqO9Tv0Yw-LmYKLc3CAfUw4gU_GlphO2D6kuASLzeJwXg_GrgVwHWaBuGY8rcc6IZ3KA8ymxLzmd5gKfDQlwFLyS3ThzZTh5um9RvefPn6_-9Lsv33-ene7b2zPaGnEgQ3KSc8F9NwJL7oDEG8HZTsnmOfc9ETUdRiM4F5xqixxnlkwXArGr9Gb89Vjir9WyEXPIVuYpvMvNZWDkr2iA61SdpbaFHOuQfUxhdmkk6ZEb0j1qDekekOqCdUVaTW9frq_HmZwfy1_GFbB-7MAasbHAElnW_NbcCGBLdrF8P_7H_6x2ylU6mb6CSfIY1xTbajm0Jlpou-3UrdOqSCUc8b5b7iGnWU</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>Fennira, Feriel, MD</creator><creator>Chasset, François, MD</creator><creator>Soubrier, Martin, MD, PhD</creator><creator>Cordel, Nadège, MD</creator><creator>Petit, Antoine, MD</creator><creator>Francès, Camille, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160601</creationdate><title>Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients</title><author>Fennira, Feriel, MD ; Chasset, François, MD ; Soubrier, Martin, MD, PhD ; Cordel, Nadège, MD ; Petit, Antoine, MD ; Francès, Camille, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-6b289d7f36e53d6f64be0fc89c4d62f33a5064d688a63f9319c0df2cea37623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Chronic Disease</topic><topic>Dermatology</topic><topic>Female</topic><topic>Humans</topic><topic>Immunologic Factors - adverse effects</topic><topic>Immunologic Factors - therapeutic use</topic><topic>Lupus Erythematosus, Cutaneous - drug therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Retreatment</topic><topic>Thalidomide - adverse effects</topic><topic>Thalidomide - analogs & derivatives</topic><topic>Thalidomide - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fennira, Feriel, MD</creatorcontrib><creatorcontrib>Chasset, François, MD</creatorcontrib><creatorcontrib>Soubrier, Martin, MD, PhD</creatorcontrib><creatorcontrib>Cordel, Nadège, MD</creatorcontrib><creatorcontrib>Petit, Antoine, MD</creatorcontrib><creatorcontrib>Francès, Camille, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fennira, Feriel, MD</au><au>Chasset, François, MD</au><au>Soubrier, Martin, MD, PhD</au><au>Cordel, Nadège, MD</au><au>Petit, Antoine, MD</au><au>Francès, Camille, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2016-06-01</date><risdate>2016</risdate><volume>74</volume><issue>6</issue><spage>1248</spage><epage>1251</epage><pages>1248-1251</pages><issn>0190-9622</issn><eissn>1097-6787</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27185425</pmid><doi>10.1016/j.jaad.2016.01.054</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0190-9622 |
| ispartof | Journal of the American Academy of Dermatology, 2016-06, Vol.74 (6), p.1248-1251 |
| issn | 0190-9622 1097-6787 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1789759181 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adult Chronic Disease Dermatology Female Humans Immunologic Factors - adverse effects Immunologic Factors - therapeutic use Lupus Erythematosus, Cutaneous - drug therapy Male Middle Aged Retreatment Thalidomide - adverse effects Thalidomide - analogs & derivatives Thalidomide - therapeutic use |
| title | Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T04%3A01%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lenalidomide%20for%20refractory%20chronic%20and%20subacute%20cutaneous%20lupus%20erythematosus:%2016%20patients&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Fennira,%20Feriel,%20MD&rft.date=2016-06-01&rft.volume=74&rft.issue=6&rft.spage=1248&rft.epage=1251&rft.pages=1248-1251&rft.issn=0190-9622&rft.eissn=1097-6787&rft_id=info:doi/10.1016/j.jaad.2016.01.054&rft_dat=%3Cproquest_cross%3E1789759181%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1789759181&rft_id=info:pmid/27185425&rft_els_id=S0190962216013323&rfr_iscdi=true |